- Atlas
- Medicine & Health
- Addiction Science
Addiction Science
Addiction science is the study of how people come to use substances—or engage in behaviours—compulsively, despite harm, and of what can be done about it.
17 frameworks, from 1700 to today · Mental Health · Medicine & Health
- Moral Model of Addiction 1700-1950
- Temperance Movement 1800-1933
- Disease Model of Addiction 1935-Present
- Twelve-Step and Minnesota Model 1935-Present
- Brain-Reward and Neurocircuitry Model 1954-Present
- Behavioural Pharmacology and Operant Learning Accounts 1960-Present
- Psychiatric Epidemiology and Natural History 1960-Present
- Opioid Substitution and Pharmacotherapy 1964-Present
- Contingency Management 1970-Present
- Social-Ecological and Risk-Environment Models 1970-Present
- Alcohol dependence 1976-Present
- Relapse Prevention 1980-Present
- Motivational Interviewing 1983-Present
- Harm Reduction 1985-Present
- Behavioral addiction 1990-Present
- Behavioural Economics of Addiction 1990-Present
- Disorder-of-Choice Account 2000-Present
Overview
Addiction science is the study of how people come to use substances—or engage in behaviours—compulsively, despite harm, and of what can be done about it1. It sits where medicine, psychology, pharmacology, neuroscience, economics and social policy meet, and its central puzzle is stubborn: why do people keep doing something they know is destroying them? The stakes are practical and enormous. Alcohol and drug use disorders account for a large share of preventable death and disability worldwide, and the field's theories have shaped not only clinics but also prisons, welfare rules, and whether a person is treated as sick or as bad. Its history is a long argument about that question—sin, will, disease, learning, brain, environment—in which the answers have repeatedly overlapped rather than replaced one another.
Temperance, Sin, and the Moral Model
For most of recorded history, excessive drinking and drug use were understood morally. The dominant frame in the Christian West was the moral model: addiction as vice, a failure of will and character, to be answered by exhortation, shame, penance, or punishment. This was not merely superstition. It carried a real insight—that behaviour is chosen and that people can change—and it left a durable mark on institutions, from the drunkard's disgrace to the criminal law that still governs much drug policy.
The moral model's great challenge came from the temperance movement. From the early nineteenth century, reformers argued that alcohol itself, not the drinker's weakness, was the danger. The American physician Benjamin Rush had argued in 1784 that habitual drunkenness was a disease and that spirits could be substituted with weaker drink; the temperance societies that followed pressed for abstinence as a collective solution. The movement's triumph was constitutional: the United States prohibited alcohol from 1920 to 1933 under the Eighteenth Amendment. Its failure—widespread illegal supply, organized crime, and the impossibility of enforcement—taught the field that supply and environment matter, and that moral legislation alone does not abolish demand.
The Disease Concept and the Birth of Alcoholism Treatment
The modern disease model crystallized in the 1930s. E. M. Jellinek, a biostatistician at what became the Yale Center of Alcohol Studies, studied the drinking histories of members of Alcoholics Anonymous and in 1952 published a phased account of alcoholism's development, including the idea of loss of control—that once drinking begins, the dependent person cannot reliably stop. Jellinek's work gave scientific form to a claim the medical profession had long resisted: that alcoholism is a condition with a predictable course, not simply a sin.
Alcoholics Anonymous, founded in 1935 by Bill Wilson and Bob Smith in Akron, Ohio, supplied the practical counterpart23. Its twelve steps framed recovery as surrender to a higher power, moral inventory, and mutual support, and its insistence that the alcoholic is powerless over alcohol meshed with the disease idea23. The Minnesota Model, developed from the late 1940s at centres such as Hazelden in Minnesota, combined AA's philosophy with residential treatment: group therapy, education about the disease, and abstinence as the goal. This model spread across North America and much of the world and made "treatment" for addiction a recognizable industry. Its critics noted that it rested on self-report and ideology as much as on controlled evidence, and that abstinence-only goals excluded people who might reduce rather than quit.
Behaviourism, Operant Accounts, and Behavioural Pharmacology
A rival tradition grew from experimental psychology. Behaviourists treated drug use as learned behaviour maintained by its consequences, and from the 1960s behavioural pharmacology put this to the test in the laboratory. Researchers trained animals to press levers for drug infusions, establishing that drugs such as cocaine, heroin, and alcohol function as reinforcers in the same sense as food. The operant account made two powerful moves: it showed that drug-seeking obeys general laws of learning, and it made the environment—cues, schedules, availability—a central variable rather than a backdrop.
This work produced concrete clinical tools. Contingency management, developed from the 1970s onward, pays patients in vouchers or prizes for verified abstinence; it is among the best-evidenced psychosocial treatments for stimulant use disorder, though its reliance on tangible rewards has made it politically awkward. Relapse prevention, formulated by G. Alan Marlatt in the 1980s, analysed relapse as a process triggered by high-risk situations and the "abstinence violation effect"—the spiral of guilt after a single lapse—and taught coping skills to interrupt it. These approaches treated addiction as a modifiable behaviour, not a fixed identity.
The Brain-Reward and Neurocircuitry Model
From the 1950s, neuroscience began to supply a biological mechanism. In 1954 James Olds and Peter Milner found that rats would press levers to stimulate certain brain regions, identifying what became known as the reward system—circuitry involving dopamine, centred on the nucleus accumbens and ventral tegmental area. Through the 1970s and 1980s, researchers showed that most addictive drugs raise dopamine in these pathways, and the idea took hold that addiction is a hijacking of the brain's natural reward machinery.
The model matured into the neurocircuitry (or brain disease) model, most associated with Nora Volkow, who from the 1990s used brain imaging to show altered dopamine function in people with addiction, and with the "three-stage" account—binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation—elaborated by George Koob and others. The claim is that repeated drug exposure produces durable changes in circuits governing reward, stress, and self-control. The model's strength is mechanistic specificity and its political usefulness: it argues for medical treatment over punishment. Its weakness is that most people who use drugs heavily do not become addicted, and that brain changes are hard to separate from the social conditions in which they occur.
Behavioural Economics and the Disorder-of-Choice Debate
A parallel line asked why people discount the future so steeply when addicted. Behavioural economics applied to addiction—notably by Warren Bickel and by A. David Redish—showed that people with substance use disorders tend to choose small immediate rewards over larger delayed ones, a measurable "delay discounting" that predicts treatment outcomes. This reframed addiction as a disorder of choice under conditions of steep temporal discounting, not a simple absence of will.
The disorder-of-choice account, argued most prominently by the philosopher and economist Gene Heyman in Addiction: A Disorder of Choice (2009), holds that addiction is voluntary behaviour shaped by its payoffs, and that most people quit when the costs—health, family, employment—become decisive. Heyman pointed to natural recovery and to the fact that many dependent people stop without treatment. Defenders of the disease model replied that choice accounts understate compulsion and the biology of withdrawal. The debate remains live and has pushed the field toward models that combine choice, learning, and neurobiology rather than choosing one.
Social-Ecological and Risk-Environment Models
Alongside the individual-level theories, a public-health tradition emphasized context. The social-ecological model treats substance use as shaped by nested levels—individual, family, peer, community, and policy—and by what are called risk environments: the availability of substances, pricing, marketing, deprivation, and social norms. This tradition descends from epidemiology and from the temperance lesson about supply. It produced effective population measures such as alcohol taxation, restrictions on outlet density, and minimum unit pricing, and it explains why addiction rates vary so much between places and times even when individual biology does not.
Pharmacotherapy and Opioid Substitution
The most consequential medical development was pharmacological. In the 1960s, Vincent Dole and Marie Nyswander at Rockefeller University introduced methadone maintenance for heroin dependence, arguing that opioid dependence is a metabolic disorder that can be stabilized by a long-acting oral opioid, allowing patients to work and live normally. The approach was controversial—critics saw it as substituting one drug for another—but it reduced crime, overdose, and HIV transmission, and it became the backbone of opioid treatment in many countries.
Later came buprenorphine, a partial opioid agonist developed in the 1970s and approved for treatment in the 1990s, and naltrexone, an opioid antagonist used for alcohol dependence. For alcohol, disulfiram (from the 1940s) deterred drinking by making it unpleasant, while acamprosate and naltrexone offered relapse reduction with better evidence. The pharmacotherapy era established that addiction has treatable biology, and it set the stage for the current dominance of medication for opioid use disorder—even as access remains uneven and stigma persists.
Motivational Interviewing and the Shift to Client-Centred Change
In the 1980s, William Miller and Stephen Rollnick developed motivational interviewing, a directive but client-centred counselling style that helps people articulate their own reasons for change rather than confronting them4. It grew from observations that confrontational approaches often increased resistance, and it reframed ambivalence as normal. Its influence spread far beyond addiction into general health care, and it became one of the most widely taught brief interventions in the field.
Harm Reduction
The HIV epidemic of the 1980s forced a reckoning. When needle sharing drove rapid HIV transmission among people who inject drugs, public-health workers in Europe and Australia pioneered harm reduction: policies that aim to reduce the harms of drug use without requiring abstinence. Needle and syringe exchange programmes, opioid substitution therapy, supervised consumption sites, and naloxone distribution followed15. Harm reduction was fiercely contested by abstinence-oriented treatment and by moral-model politics, but it accumulated strong evidence for reducing HIV, hepatitis, and overdose death, and it is now embedded in the policy of many countries and in the World Health Organization's guidance.
The Present: Integrated Models and Open Questions
Today's addiction science is plural by design. The brain-disease model remains the dominant public framing and the basis for much funding and medication development, but it is increasingly combined with learning theory, behavioural economics, and social-ecological analysis. Contingency management, motivational interviewing, relapse prevention, and medication-assisted treatment coexist in clinical guidelines, and harm reduction sits alongside them as a public-health pillar1. The field's open questions are substantial: why most heavy users never become addicted; how to treat stimulant use disorder, for which no medication is approved; how to reduce the stigma that keeps people out of care; and how to reconcile the evidence that addiction is partly chosen with the evidence that it is partly biological. The argument that began with sin and will has not ended—it has simply acquired more instruments.
References
- Addiction (introduction, Harm reduction, Psychological and behavioral), Wikipedia
- Twelve-step program (introduction, History), Wikipedia
- Alcoholics Anonymous, Wikipedia
- Motivational interviewing, Wikipedia
- Harm reduction, Wikipedia
The frameworks of Addiction Science
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1700-1950
- 1800-1933
- 1935-Present
- 1935-Present
Twelve-Step and Minnesota Model
How do people recover from addiction together?
- 1954-Present
Brain-Reward and Neurocircuitry Model
What brain changes make drug use compulsive?
- 1960-Present
Behavioural Pharmacology and Operant Learning Accounts
What consequences maintain drug-seeking behaviour?
- 1960-Present
Psychiatric Epidemiology and Natural History
How common is addiction and how does it unfold?
- 1964-Present
Opioid Substitution and Pharmacotherapy
Can a drug treat drug dependence?
- 1970-Present
- 1976-Present
- 1980-Present
- 1983-Present
- 1985-Present
- 1990-Present
- 1990-Present
Behavioural Economics of Addiction
Why do addicted people discount the future?
- 2000-Present
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Disease Model of Addiction reacted against Moral Model of Addiction
The disease model defined itself against the moral model, arguing that alcoholism is a predictable condition rather than a vice or failure of will. Jellinek's 1952 phased account and the medical advocacy around it gave scientific form to this rejection of moral blame.
Carried by E. M. Jellinek.
Disease Model of Addiction influenced by Twelve-Step and Minnesota Model
Alcoholics Anonymous's insistence that the alcoholic is powerless over alcohol meshed with the emerging disease idea, and the Minnesota Model later combined AA's twelve steps with residential treatment and education about the disease. The treatment industry that grew from Hazelden and similar centres was built directly on the disease concept.
Carried by Bill Wilson; Bob Smith; Hazelden.
Contingency Management grew out of Behavioural Pharmacology and Operant Learning Accounts
Contingency management grew directly out of the operant laboratory finding that drugs function as reinforcers and that drug-seeking obeys schedules of reinforcement. Researchers applied the same reinforcement principles clinically, paying patients in vouchers for verified abstinence.
Carried by Stephen Higgins.
Relapse Prevention grew out of Behavioural Pharmacology and Operant Learning Accounts
Marlatt's relapse prevention was built on the behavioural pharmacology and operant account of drug use as learned behaviour maintained by consequences. It analysed relapse as a process triggered by high-risk situations and taught coping skills to interrupt it, extending the learning model into clinical practice.
Carried by G. Alan Marlatt.
Temperance Movement reacted against Moral Model of Addiction
Temperance reformers rejected the moral model's focus on the drinker's will and vice, arguing instead that alcohol itself was the danger and that collective abstinence, not individual penance, was the remedy. Benjamin Rush's 1784 claim that habitual drunkenness was a disease and that spirits could be replaced by weaker drink fed the movement's environmental emphasis.
Carried by Benjamin Rush; American Temperance Society.
Opioid Substitution and Pharmacotherapy influenced by Disease Model of Addiction
Dole and Nyswander's argument for methadone maintenance rested on the disease model's premise that opioid dependence is a metabolic condition to be treated medically rather than a vice to be punished. Their 1965 work at Rockefeller University carried the disease framing into pharmacotherapy.
Carried by Vincent Dole; Marie Nyswander.
Alcohol dependence grew out of Disease Model of Addiction
The modern diagnostic category of alcohol dependence, codified in the 1970s and 1980s, grew out of the disease model's claim that alcoholism has a recognizable course and cluster of symptoms. Jellinek's phased account and the loss-of-control idea supplied the clinical features that later criteria formalized.
Carried by E. M. Jellinek; Griffith Edwards.
Harm Reduction reacted against Disease Model of Addiction
Harm reduction arose as a rejection of the disease model's abstinence-only goal, arguing that people who continue to use should be helped to do so more safely. Needle exchange and other measures defined themselves against the treatment industry's insistence on quitting.
Motivational Interviewing reacted against Twelve-Step and Minnesota Model
Motivational interviewing was developed partly in reaction to the confrontational, abstinence-only style of the Minnesota Model and twelve-step treatment. Miller and Rollnick replaced exhortation and confrontation with a client-centred approach that elicits the person's own reasons for change.
Carried by William R. Miller; Stephen Rollnick.
Disorder-of-Choice Account reacted against Brain-Reward and Neurocircuitry Model
Heyman's disorder-of-choice account defined itself against the brain-disease claim that addiction is a compulsion rooted in durable neural change. He argued that most dependent people quit when costs become decisive, directly challenging the neurocircuitry model's interpretation of the evidence.
Carried by Gene Heyman; Addiction: A Disorder of Choice (2009).
Behavioural Economics of Addiction influenced by Behavioural Pharmacology and Operant Learning Accounts
Behavioural economics of addiction took the operant insight that drug use is choice shaped by consequences and recast it in terms of delay discounting and intertemporal choice. Bickel and others measured steep temporal discounting in people with substance use disorders, extending the learning account into economic choice.
Carried by Warren Bickel; A. David Redish.
Disorder-of-Choice Account influenced by Behavioural Economics of Addiction
Heyman's disorder-of-choice account drew on the behavioural-economic finding that addicted people discount the future steeply and respond to changing payoffs. It reframed addiction as voluntary behaviour shaped by its consequences rather than a simple absence of will.
Carried by Gene Heyman.
Behavioral addiction influenced by Behavioural Pharmacology and Operant Learning Accounts
The behavioural account of drug use as learned behaviour maintained by reinforcement supplied a template for extending the concept of addiction to non-substance behaviours such as gambling. The same operant logic was applied to behavioural addictions from the 1990s.
Beyond the field
Where Addiction Science's ideas came from in other fields, and what they led to there: the strongest 12 of 60 links.
Moral Model of Addiction provoked Disease Model of Addiction in Substance Use Social Work
The disease model defined itself against the moral model, arguing that addiction is illness rather than sin or weakness of will. Jellinek and later medical writers explicitly rejected the moral framing as unscientific and stigmatizing.
Carried by E. M. Jellinek.
Behavioural Pharmacology and Operant Learning Accounts grew out of Operant conditioning in Behavioral Neuroscience
Behavioural pharmacology of addiction grew directly out of Skinnerian operant conditioning, using self-administration schedules and reinforcement concepts to explain drug-seeking. Researchers such as those around the 1960s intravenous self-administration work applied operant methods to drugs as reinforcers.
Carried by B. F. Skinner.
Opioid Substitution and Pharmacotherapy influenced by Psychopharmacology in Psychiatry
Psychopharmacology provided the clinical rationale and trial methods for methadone maintenance; Dole and Nyswander's 1965 work framed heroin addiction as a metabolic disorder treatable by opioid substitution. The dosing and outcome measures came from the psychopharmacological tradition.
Carried by Vincent Dole; Marie Nyswander.
Alcohol dependence influenced by Disease Model of Addiction in Substance Use Social Work
The disease model of addiction, especially Jellinek's work, provided the framework within which alcohol dependence was defined as a syndrome with a predictable course. Edwards and Gross built their dependence syndrome concept on this tradition while revising it.
Carried by E. M. Jellinek; Griffith Edwards; Milton Gross.
Relapse Prevention grew out of Behaviour therapy in Substance Use Social Work
Relapse prevention was built directly on behaviour therapy's functional analysis and skills-training methods, recasting relapse as a learned response to high-risk situations. Marlatt and Gordon's model is an application and extension of behavioural principles.
Carried by G. Alan Marlatt; Judith R. Gordon.
Motivational Interviewing influenced Screening, Brief Intervention and Referral to Treatment in Substance Use Social Work
The brief intervention component of SBIRT is built on motivational interviewing: the developers specified MI-consistent brief advice and counselling as the intervention brief primary-care staff deliver.
Carried by William R. Miller; Stephen Rollnick.
Behavioural Economics of Addiction influenced by Hyperbolic Discounting in Behavioral Decision Theory
Hyperbolic discounting, formalised by Ainslie and others, became the core mechanism in behavioural economic models of addiction, explaining preference reversals and relapse.
Carried by George Ainslie; Richard Herrnstein.
Disorder-of-Choice Account reacted against Disease Model of Addiction in Substance Use Social Work
The disorder-of-choice account was formulated as a direct challenge to the disease model, arguing that addiction is a voluntary, choice-driven disorder rather than a brain disease.
Carried by Gene M. Heyman; Addiction: A Disorder of Choice (2009).
Moral Model of Addiction influenced Temperance movement in Substance Use Social Work
Temperance reformers carried the older moral view of drunkenness as sin and vice into organized campaigning, framing drink as a moral failing to be cured by pledge and conversion. This supplied the moral model of addiction its central premise.
Moral Model of Addiction influenced by Virtue ethics in Normative Ethics
The moral model of addiction inherited its core claim that drunkenness is a vice and a failure of self-governance from virtue ethics, especially the Aristotelian and later Christian treatments of temperance as a virtue. Nineteenth-century temperance writers and moral reformers drew directly on this vocabulary of vice and self-control when framing habitual drinking as a moral failing.
Carried by Aristotle; Thomas Aquinas.
Moral Model of Addiction influenced by Virtue ethics in Ethics
The moral model of addiction inherited its core claim that drunkenness is a vice and a failure of self-governance from virtue ethics, especially the Aristotelian and later Christian treatments of temperance as a virtue. Nineteenth-century temperance writers and moral reformers drew directly on this vocabulary of vice and self-control when framing habitual drinking as a moral failing.
Carried by Aristotle; Thomas Aquinas.
Temperance Movement influenced Minnesota Model and Abstinence-Based Treatment in Substance Use Social Work
The Minnesota Model inherited the temperance commitment to total abstinence as the only goal, carried through AA into hospital-based treatment. Its insistence on lifelong sobriety descends from that tradition.

Addiction Science is a planet in Nousfarer
Its city has a tower for each of these 17 frameworks. Land, walk in, and climb one concept at a time.
Land on Addiction ScienceRelated fields
Fields its ideas are linked to
- Substance Use Social Work 27 links
- Mental Health 3 links
- Psychiatry 3 links
- Behavioral Neuroscience 3 links
- Community Mental Health 2 links
- Adolescent Medicine 2 links
- Clinical Psychology 2 links
- Behavioral Decision Theory 1 link
- Reasoning Decision Making 1 link
- Crime Prevention 1 link
- Neoclassical Economics 1 link
- Pulmonology 1 link
More in Mental Health
- Child And Adolescent Psychiatry
- Community Mental Health
- Developmental Psychopathology
- Forensic Psychiatry
- Mental Health
- Mental Health Policy And Systems
- Psychiatry
- Psychopathology
- Psychopharmacology
- Psychotherapy
See where Addiction Science sits on the Map of Human Knowledge